Dr Stocker, a Senior Lecturer at the School of Pharmacy, Sydney University, also holds an Honorary Senior Hospital Scientist appointment in the Department of Clinical Pharmacology and Toxicology at St Vincent’s Hospital, Sydney, Australia. Dr Stocker received her PhD from the University of Sydney and performed postdoctoral studies at the University of New South Wales and the University of California San Francisco. Dr Stocker joined the Ethnopharmacology group at GlaxoSmithKline in 2012 and then the Department of Clinical Pharmacology and Toxicology at St Vincent’s Hospital, Sydney in 2015. In 2020, Dr Stocker joined the School of Pharmacy at the University of Sydney. Dr Stocker’s research focuses on understanding variability in response to medicines and how this can be managed to optimise patient care. Her research program involves the application of clinical pharmacology, ethnopharmacology, pharmacogenomics, pharmacometrics, implementation science, health service delivery and qualitative research to optimise medicine use in several therapeutic areas including anti-infectives, gout, diabetes and transplant medicine. She is internationally recognised for implementation of precision dosing software and other precision medicine approaches. Dr Stocker has co-authored more than 120 papers and holds several committee positions in national and international societies. She has gained recognition of leadership internationally (Victor Armstrong Young Investigator Award, 2022), and nationally (CERTARA Young Investigator and the APSA Emerging Leader Award, 2020).

Senthil Lingaratnam is the Director of Pharmacy at the Peter MacCallum Cancer Centre. He has a masters in public health and is currently undertaking a part-time PhD in personalised medicine strategies in cancer care at Monash University with Prof Carl Kirkpatrick as his supervisor.

Bronwyn Terrill is a genomics educator, researcher and communicator at Garvan Institute of Medical Research and Australian Genomics, and a conjoint lecturer at UNSW Sydney. Bronwyn is trained in science and has postgraduate qualifications in science education, scientific and technical writing and science communication. Bronwyn has extensive experience developing genetics-focused resources, programs and campaigns for public and professional audiences in the UK, US and Australia. She has been involved in education and health research since 2015 spanning public genetic literacy, genomics education of health professionals, and public expectations of personal genomics. She is currently an investigator on studies implementing genomic medicine on a national scale, genomic screening in newborns and young people, and the use of artificial intelligence in genetic diagnosis. As a practitioner-researcher, Bronwyn has co-authored peer-reviewed publications on the development and evaluation of learning materials in genomics and shifts in clinical practice with genomic testing.

Dr Nuala Helsby (FBPhS) is an associate professor in Pathology at the University of Auckland. Her research focus is on understanding how both inherited and environmental factors influence the safe and effective use of drugs. Nuala has more than 30 years of experience in the field of drug metabolism and pharmacogenetics (orcid.org/0000-0001-6570-5368). She teaches extensively in the Biomedical Science and Pharmacology programmes and also serves on a number of NZ-based grant assessment panels.